United States Anti-Doping Agency Reauthorization Act
Official title: A bill to reauthorize the United States Anti-Doping Agency, and for other purposes.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Became Public Law No: 113-280.
(This measure has not been amended since it was introduced. The summary of that version is repeated here.)
United States Anti-Doping Agency Reauthorization Act - Amends the Office of National Drug Control Policy Reauthorization Act of 2006 to: (1) authorize appropriations for the U.S. Anti-Doping Agency for FY2014-FY2020, (2) require that the Agency be recognized worldwide as the independent national anti-doping organization for the United States, and (3) replace the Agency's role in preventing the use by U.S. amateur athletes of performance-enhancing genetic modifications accomplished through gene doping with a role in preventing the use of prohibited performance-enhancing methods adopted by the Agency.
- Engrossed in Senate Formatted Text PDF Formatted XML
- Enrolled Bill Formatted Text PDF Formatted XML
- Introduced in Senate Formatted Text PDF Formatted XML
- Public Law Formatted Text PDF United States Legislative Markup
- Reported to Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 2338: United States Anti-Doping Agency Reauthorization Act. 113th Congress. Open America. https://openamerica.io/bill/113-S-2338/
"S. 2338: United States Anti-Doping Agency Reauthorization Act." 113th Congress, 2026, Open America, https://openamerica.io/bill/113-S-2338/.
S. 2338, 113th Cong. (2026), https://openamerica.io/bill/113-S-2338/.
[S. 2338: United States Anti-Doping Agency Reauthorization Act](https://openamerica.io/bill/113-S-2338/)